Highlights of the guidelines of prevention and treatment for hepatitis C (2019 version)
10.3760/cma.j.issn.1007-3418.2020.02.005
- VernacularTitle:《丙型肝炎防治指南(2019年版)》重要更新
- Author:
Huiying RAO
1
;
Zhongping DUAN
;
Guiqiang WANG
;
Lai WEI
Author Information
1. 北京大学人民医院北京大学肝病研究所 100044
- Keywords:
Hepatitis C;
Treatment;
Prevention;
Guidelines;
Highlights
- From:
Chinese Journal of Hepatology
2020;28(2):129-132
- CountryChina
- Language:Chinese
-
Abstract:
The key points from the updated guideline of prevention and treatment for hepatitis C (2019 version) is compared with the previous hepatitis C guideline.A new terminology and the World Health Organization's goal of eliminating viral hepatitis as a public-health threat by 2030 are stressed.In the prevention section,the screening for hepatitis C virus infection in high-risk population is the primary means of prevention,emphasizing that treatment,is prevention.In the aspect of treatment,pangenotypic interferon-free scheme are initial recommendations.In addition,it also introduces our country independent research and development on direct-acting antiviral agents,and antiviral therapy schedule for many special populations,including decompensated liver cirrhosis,chronic kidney disease,children and adolescents combined with chronic kidney injury,HBV infection-before and after liver transplantation,treatment failure,and acute hepatitis C.A simplified on-treatment monitoring schedule,especially genotype 3 prevalent in Southwest part of our country is introduced.
